Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals
Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services
연구 개요
상세 설명
Background:
The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.
Objectives:
The aims of this international online survey are
- To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.
- To assess the experiences made with the established services so far.
- To assess the need for networking, cooperation and support.
- Improvement of psychosocial care in acute hospitals in the context of pandemics.
Study Design:
This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.
There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).
Ethic approval:
In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.
Setting:
The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.
Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.
Country specific regions:
The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.
Online survey questionnaire:
Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.
The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
-
Thessaloniki, 그리스
- Aristotle University Thessaloniki
-
-
-
-
-
Oslo, 노르웨이
- Oslo University Hospital
-
-
-
-
Bayern
-
Nürnberg, Bayern, 독일, 90419
- Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy
-
-
Nordrhein-Westfalen
-
Köln, Nordrhein-Westfalen, 독일, 50937
- University Hospital Cologne, Department of Psychosomatics and Psychotherapy
-
-
-
-
-
Ghent, 벨기에
- Ghent University Hospital, Department of Psychiatry
-
-
-
-
-
Basel, 스위스, 4002
- University of Basel, Department of Psychiatry (UPK)
-
-
Basel-City
-
Basel, Basel-City, 스위스, 4031
- University Hospital Basel, Department of Psychosomatic Medicine
-
-
-
-
-
Barcelona, 스페인
- Barcelona University
-
-
-
-
-
Dublin, 아일랜드
- University College Dublin
-
-
-
-
-
Exeter, 영국
- University of Exeter
-
York, 영국
- University of York
-
-
-
-
Steiermark
-
Graz, Steiermark, 오스트리아, 8036
- Medical University of Graz, University Hospital Graz
-
-
-
-
-
Tehran, 이란, 이슬람 공화국
- University of Medical Sciences, Department of Psychiatry
-
-
-
-
-
Bologna, 이탈리아, 40123
- Bologna University
-
Modena, 이탈리아, 411274
- University of Modena & Reggio Emilia
-
-
-
-
-
Montreal, 캐나다
- University of Montreal, Department of Psychosomatic Medicine
-
Toronto, 캐나다
- TorontoSinai Health, University of Toronto, Department of Psychiatry
-
-
-
-
-
Lisboa, 포르투갈
- Hospital de Santa Maria
-
Lisboa, 포르투갈
- Universidade Católica Portuguesa Lisboa
-
-
-
-
-
Wroclaw, 폴란드
- Wroclaw Medical University
-
-
-
-
-
Paris, 프랑스
- Université de Paris, Service de Psychiatrie de l'adulte
-
-
-
-
-
Oulu, 핀란드, 90220
- Oulu University Hospital and University of Oulu
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries
Exclusion Criteria:
- None
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Structural and process quality of COVID-19 related psychosocial C&L services
기간: 6 months
|
Data basis for improving quality of COVID-19 related psychosocial C&L services:
|
6 months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Rainer Schaefert, Prof. Dr. med., University Hospital, Basel, Switzerland
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- Req-2020-00861; th21Schaefert
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .